Shinji Nakane

4.6k citations

21 papers · 3.8k indexed · 1 hit paper · h-index 18

Pharmacology top 0.1%
- Cannabis and Cannabinoid Research 15
Toxicology top 0.2%
- Forensic Toxicology and Drug Analysis 4
Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research 3
Endocrine and Autonomic Systems top 1%
Cognitive Neuroscience top 2%
Pathology and Forensic Medicine
- Alcohol Consumption and Health Effects 6
Molecular Biology
- Sphingolipid Metabolism and Signaling 5
- Lipid Membrane Structure and Behavior 3
Biochemistry
- Lipid metabolism and biosynthesis 5
Plant Science
- GABA and Rice Research 3

Co-authors: Takayuki Sugiura Keizo Waku Atsushi Yamashita Shigeru Kondo Akira Shinoda Kohji Itoh Sachiko Kondo Tomoko Kodaka
Cited by: Pharmacology Toxicology Cellular and Molecular Neuroscience
Journals: Biochemical and Biophysical Research Communications (5 papers)Journal of Biological Chemistry (3 papers)European Journal of Biochemistry (1 paper)
Partner nations: Japan United States

In The Last Decade

Shinji Nakane

21 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Shinji Nakane

Since Specialization

Citations

This map shows the geographic impact of Shinji Nakane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Nakane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Nakane more than expected).

Fields of papers citing papers by Shinji Nakane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinji Nakane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Nakane. The network helps show where Shinji Nakane may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shinji Nakane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shinji Nakane Line = papers co-authored together Shinji Nakane links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of 9-Hydroxyoctadecadienoic Acid and Other Oxidized Free Fatty Acids as Ligands of the G Protein-coupled Receptor G2A Journal of Biological Chemistry ·Hideru Obinata,Tomoyasu Hattori,Shinji Nakane,Kazuaki Tatei,Takashi Izumi	2005	142
2	Lysophosphatidic acid, a growth factor-like lipid, in the saliva Journal of Lipid Research ·Takayuki Sugiura,Shinji Nakane,Seishi Kishimoto,Keizo Waku,Yasuko Yoshioka,Akira Tokumura	2002	106
3	2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain Archives of Biochemistry and Biophysics ·Shinji Nakane,Saori Oka,Aubrie G Booth,Keizo Waku,Yoshio Ishima,Akira Tokumura,Takayuki Sugiura	2002	86
4	2-Arachidonoylglycerol and Anandamide Oppositely Modulate Norepinephrine Release from the Rat Heart Sympathetic Nerves The Japanese Journal of Pharmacology ·Junichi Kurihara,Annabelle M. Melville.,S Cr'ptio ' Ix Formation,Chin Eng Teh,Yoshinobu Takata,Shinji Nakane,Takayuki Sugiura,Keizo Waku,Hitoshi Kato	2001	14
5	Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand Bioorganic & Medicinal Chemistry Letters ·Yoshitomo Suhara,Shinji Nakane,Aubrie G Booth,Hiroaki Takayama,Keizo Waku,Yoshio Ishima,Takayuki Sugiura	2001	9
6	Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor‐like lipids: Distinct Molecular species compositions Lipids ·Shinji Nakane,Akira Tokumura,Keizo Waku,Takayuki Sugiura	2001	47
7	Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor Journal of Biological Chemistry ·Takayuki Sugiura,Sachiko Kondo,Seishi Kishimoto,Tomoyuki Miyashita,Shinji Nakane,Tomoko Kodaka,Yoshitomo Suhara,Hiroaki Takayama,Keizo Waku	2000	317
8	Occurrence of a Novel Cannabimimetic Molecule 2-Sciadonoylglycerol (2-Eicosa-5',11',14'-trienoylglycerol) in the Umbrella Pine Sciadopitys verticillata Seeds. Biological and Pharmaceutical Bulletin ·Shinji Nakane,Tamotsu Tanaka,Kiyoshi Satouchi,Yuriko Kobayashi,Keizo Waku,Takayuki Sugiura	2000	24
9	Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor Journal of Biological Chemistry ·Takayuki Sugiura,Tomoko Kodaka,Shinji Nakane,Tomoyuki Miyashita,Sachiko Kondo,Yoshitomo Suhara,Hiroaki Takayama,Keizo Waku,Mason Marchetti,Naomichi Baba,Yoshio Ishima	1999	262
10	Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Takayuki Sugiura,Shinji Nakane,Seishi Kishimoto,Keizo Waku,Yasuko Yoshioka,Akira Tokumura,Donald J. Hanahan	1999	86
11	Detection of an Endogenous Cannabimimetic Molecule, 2-Arachidonoylglycerol, and Cannabinoid CB1 Receptor mRNA in Human Vascular Cells: Is 2-Arachidonoylglycerol a Possible Vasomodulator? Biochemical and Biophysical Research Communications ·Takayuki Sugiura,Tomoko Kodaka,Shinji Nakane,Seishi Kishimoto,Sachiko Kondo,Keizo Waku	1998	126
12	2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca²⁺‐dependent and ‐independent mechanisms FEBS Letters ·Sachiko Kondo,Huỳnh Văn Rạng,Shinji Nakane,Tomoko Kodaka,Akira Tokumura,Keizo Waku,Takayuki Sugiura	1998	121
13	Is the Cannabinoid CB1 Receptor a 2-Arachidonoylglycerol Receptor? Structural Requirements for Triggering a Ca2+ Transient in NG108-15 Cells The Journal of Biochemistry ·Takayuki Sugiura,T. Kodaka,Shigeru Kondo,Shinji Nakane,Hisatake Kondo,Keizo Waku,Yu Ishima,Kazuhito Watanabe,Ikuo Yamamoto	1997	109
14	Inhibition by 2-Arachidonoylglycerol, a Novel Type of Possible Neuromodulator, of the Depolarization-Induced Increase in Intracellular Free Calcium in Neuroblastoma × Glioma Hybrid NG108-15 Cells Biochemical and Biophysical Research Communications ·Takayuki Sugiura,Tomoko Kodaka,Sachiko Kondo,Takashi Tonegawa,Shinji Nakane,Seishi Kishimoto,Atsushi Yamashita,Keizo Waku	1997	59
15	Enzymatic synthesis of oleamide (cis‐9,10‐octadecenoamide), an endogenous sleep‐inducing lipid, by rat brain microsomes IUBMB Life ·Takayuki Sugiura,Sachiko Kondo,Tomoko Kodaka,Takashi Tonegawa,Shinji Nakane,Atsushi Yamashita,Yoshio Ishima,Keizo Waku	1996	36
16	Enzymatic Synthesis of Anandamide, an Endogenous Cannabinoid Receptor Ligand, through N-Acylphosphatidylethanolamine Pathway in Testis: Involvement of Ca2+-Dependent Transacylase and Phosphodiesterase Activities Biochemical and Biophysical Research Communications ·Takayuki Sugiura,Sachiko Kondo,Roman Smelík,Takashi Tonegawa,Shinji Nakane,Atsushi Yamashita,Keizo Waku	1996	170
17	Transacylase‐Mediated and Phosphodiesterase‐Mediated Synthesis ofN‐Arachidonoylethanolamine, an Endogenous Cannabinoid‐Receptor Ligand, in Rat Brain Microsomes European Journal of Biochemistry ·Takayuki Sugiura,Sachiko Kondo,Roman Smelík,Takashi Tonegawa,Shinji Nakane,Atsushi Yamashita,Yoshio Ishima,Keizo Waku	1996	187
18	N-Arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues PubMed ·Takayuki Sugiura,Sachiko Kondo,Roman Smelík,Takashi Tonegawa,Shinji Nakane,Atsushi Yamashita,Keizo Waku	1996	17
19	2-Arachidonoylglycerol, a Putative Endogenous Cannabinoid Receptor Ligand, Induces Rapid, Transient Elevation of Intracellular Free Ca2+in Neuroblastoma × Glioma Hybrid NG108-15 Cells Biochemical and Biophysical Research Communications ·Takayuki Sugiura,Tomoko Kodaka,Sachiko Kondo,Takashi Tonegawa,Shinji Nakane,Seishi Kishimoto,Atsushi Yamashita,Keizo Waku	1996	139
20	2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brainbreakdown → Biochemical and Biophysical Research Communications ·Takayuki Sugiura,Shigeru Kondo,Roman Smelík,Shinji Nakane,Akira Shinoda,Kohji Itoh,Atsushi Yamashita,Keizo Waku	1995	1761

About Shinji Nakane

Shinji Nakane is a scholar working on Toxicology, Pharmacology and Biochemistry, having authored 21 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (15 papers), Alcohol Consumption and Health Effects (6 papers), Sphingolipid Metabolism and Signaling (5 papers), Lipid metabolism and biosynthesis (5 papers), Forensic Toxicology and Drug Analysis (4 papers), Neuroscience and Neuropharmacology Research (3 papers), GABA and Rice Research (3 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Pharmacology (3.2k citations), Toxicology (486 citations) and Cellular and Molecular Neuroscience (1.6k citations). Shinji Nakane has collaborated with scholars based in Japan and United States. Frequent co-authors include Takayuki Sugiura, Keizo Waku, Atsushi Yamashita, Shigeru Kondo, Akira Shinoda, Kohji Itoh, Sachiko Kondo, Tomoko Kodaka, Seishi Kishimoto and Takashi Tonegawa. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Biological Chemistry, European Journal of Biochemistry, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact